LOADING
Comparing NVIDIA Corporation (NVDA) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | PFE |
|---|---|---|
| Price | $214.72 | $28.07 |
| Change Today | -0.98% | +1.01% |
| Market Cap | $5.20T | $160.0B |
| P/E Ratio | 32.9 | 36.9 |
| Forward P/E | 24.5 | 9.5 |
| PEG Ratio | 0.59 | 2.72 |
| EPS | $6.53 | $0.76 |
| Revenue Growth (YoY) | 85.2% | 2.6% |
| Profit Margin | 63.0% | 6.8% |
| Return on Equity | 114.3% | 5.0% |
| Dividend Yield | 0.02% | 6.19% |
| Beta | 2.21 | 0.28 |
| 52-Week High | $236.26 | $28.44 |
| 52-Week Low | $163.85 | $22.03 |
| Volume | 98.9M | 37.1M |
NVIDIA Corporation is the larger company by market capitalization. NVIDIA Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.